A detailed history of Proficio Capital Partners LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Proficio Capital Partners LLC holds 4,459 shares of ABT stock, worth $526,741. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,459
Previous 8,073 44.77%
Holding current value
$526,741
Previous $838,000 39.38%
% of portfolio
0.05%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$100.07 - $118.13 $361,652 - $426,921
-3,614 Reduced 44.77%
4,459 $508,000
Q2 2024

Jul 25, 2024

BUY
$100.73 - $112.44 $19,541 - $21,813
194 Added 2.46%
8,073 $838,000
Q1 2024

May 02, 2024

BUY
$109.52 - $120.96 $23,327 - $25,764
213 Added 2.78%
7,879 $895,000
Q4 2023

Feb 13, 2024

BUY
$90.19 - $110.4 $37,068 - $45,374
411 Added 5.67%
7,666 $843,000
Q3 2023

Oct 18, 2023

SELL
$95.53 - $114.62 $6,018 - $7,221
-63 Reduced 0.86%
7,255 $702,000
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $40,916 - $45,589
406 Added 5.87%
7,318 $797,000
Q1 2023

Apr 21, 2023

SELL
$96.86 - $114.01 $67.2 Million - $79.1 Million
-693,620 Reduced 99.01%
6,912 $699,000
Q1 2023

Apr 19, 2023

BUY
$96.86 - $114.01 $67.1 Million - $79 Million
693,110 Added 9338.59%
700,532 $70.9 Million
Q4 2022

Jan 30, 2023

BUY
$95.06 - $111.52 $47,434 - $55,648
499 Added 7.21%
7,422 $815,000
Q3 2022

Oct 11, 2022

SELL
$96.76 - $112.03 $8,998 - $10,418
-93 Reduced 1.33%
6,923 $688,000
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $108,296 - $130,895
-1,061 Reduced 13.14%
7,016 $762,000
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $101,135 - $123,328
887 Added 12.34%
8,077 $956,000
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $4,852 - $5,941
42 Added 0.59%
7,190 $1.01 Million
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $18,665 - $20,649
-160 Reduced 2.19%
7,148 $844,000
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $10,579 - $12,453
100 Added 1.39%
7,308 $847,000
Q1 2021

May 14, 2021

BUY
$108.84 - $128.23 $215,503 - $253,895
1,980 Added 37.87%
7,208 $864,000
Q4 2020

Feb 11, 2021

BUY
$105.0 - $114.42 $76,440 - $83,297
728 Added 16.18%
5,228 $572,000
Q3 2020

Nov 02, 2020

BUY
$91.64 - $111.29 $24,009 - $29,157
262 Added 6.18%
4,500 $470,000
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $37,366 - $47,824
488 Added 13.01%
4,238 $387,000
Q1 2020

May 06, 2020

BUY
$62.82 - $91.86 $235,575 - $344,475
3,750 New
3,750 $331,000
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $126,770 - $137,458
-1,549 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$72.88 - $85.0 $44,748 - $52,190
614 Added 65.67%
1,549 $130,000
Q1 2019

May 13, 2019

BUY
$66.22 - $80.06 $3,840 - $4,643
58 Added 6.61%
935 $75,000
Q4 2018

Feb 08, 2019

SELL
$65.56 - $74.27 $655 - $742
-10 Reduced 1.13%
877 $63,000
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $4,013 - $4,841
-66 Reduced 6.93%
887 $65,000
Q1 2018

May 14, 2018

BUY
$56.27 - $63.62 $3,094 - $3,499
55 Added 6.12%
953 $57,000
Q4 2017

Feb 09, 2018

BUY
$53.68 - $57.47 $805 - $862
15 Added 1.7%
898 $51,000
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $42,436 - $47,364
883
883 $47,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Proficio Capital Partners LLC Portfolio

Follow Proficio Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.